The recent ruling (21 November 2018) of the European Court of Justice puts an end to the dispute over the off-label use of bevacizumab for age-related macular degeneration.
Perspectives
Focus on
A widely used class of antibioticsQuinolones and fluoroquinolones are broad-spectrum synthetic antimicrobials that are highly effective in treating a wide range of infections. Although these drugs represent a class of antibiotics of considerable medical importance, their use as a first-line...
Columns
Phytovigilance & Supplements
In recent years there has been an increase in the use of complementary and alternative medicines (CAM) in the general population, in paediatrics and also during pregnancy and lactation. This phenomenon is largely due to the fact that complementary medicine practices and even more natural products...
From regulatory agencies
| 17 May 2019 EMA | 17 May 2019 EMA |
| 16 May 2019 FDA | 16 May 2019 FDA |
| 14 May 2019 AIFA | 07 May 2019 CADTH |
| 06 May 2019 AIFA | 03 May 2019 FDA |
| 30 April 2019 EMA | 26 April 2019 EMA |